BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19215799)

  • 1. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
    Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biology of chronic myeloid leukemia].
    Hellmann A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
    Koduru P; Goh JC; Allen SL; Karp L; Jasti H; DeMarco LC; Lichtman SM
    Hematol Pathol; 1991; 5(2):57-66. PubMed ID: 1894583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin alterations surrounding the BCR/ABL fusion gene in K562 cells.
    Schaefer-Rego KE; Leibowitz D; Mears JG
    Oncogene; 1990 Nov; 5(11):1669-73. PubMed ID: 2267134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.
    Wada H; Mizutani S; Nishimura J; Usuki Y; Kohsaki M; Komai M; Kaneko H; Sakamoto S; Delia D; Kanamaru A
    Cancer Res; 1995 Jul; 55(14):3192-6. PubMed ID: 7606740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia as a model for the genetic basis of cancer.
    Cannistra SA
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):337-57. PubMed ID: 2182595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of Philadelphia chromosome positive leukaemias.
    Young BD
    Br J Cancer Suppl; 1988 Dec; 9():58-61. PubMed ID: 3076066
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer genetics. Imprinting in leukaemia.
    Reik W
    Nature; 1992 Oct; 359(6394):362-3. PubMed ID: 1406944
    [No Abstract]   [Full Text] [Related]  

  • 13. BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.
    Mohamed AN; Koppitch F; Varterasian M; Karanes C; Yao KL; Sarkar FH
    Genes Chromosomes Cancer; 1995 Jun; 13(2):133-7. PubMed ID: 7542908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes.
    Chen Z; Morgan R; Berger CS; Pearce-Birge L; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1993 Oct; 70(2):103-7. PubMed ID: 8242587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia.
    Zhang J; Meltzer P; Jenkins R; Guan XY; Trent J
    Blood; 1993 Jun; 81(12):3365-71. PubMed ID: 8507874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Philadelphia chromosome: from the gene to therapeutic methods].
    Pérez-Losada J; González-Sarmiento R; Sánchez-García I
    Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
    James H; Mills K; Gibson I
    Leukemia; 1996 Jun; 10(6):1054-64. PubMed ID: 8667643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.
    Tkachuk DC; Westbrook CA; Andreeff M; Donlon TA; Cleary ML; Suryanarayan K; Homge M; Redner A; Gray J; Pinkel D
    Science; 1990 Oct; 250(4980):559-62. PubMed ID: 2237408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular confirmation of BCR-ABL fusion in a chronic myeloid leukemia with a complex translocation involving chromosomes 9, 15, and 22.
    Tharapel SA; Vnencak-Jones CL; Whitlock JA; Jain R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):343-5. PubMed ID: 1377943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
    Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.